MutualFundWire.com: Barron's Ponders the Tactics of Three Fido Funds
MutualFundWire.com
   The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
Monday, January 13, 2014

Barron's Ponders the Tactics of Three Fido Funds


Barron's writer Brendan Conway analyzes three Fidelity funds and their tactics within regards to the the stocks of Intercept Pharmaceuticals, which surged 582% in 2013. The funds analyzed were the Fidelity Select Biotechnology, Fidelity Select Healthcare, and the Fidelity Contrafund.


Printed from: MFWire.com/story.asp?s=47309

Copyright 2014, InvestmentWires, Inc.
All Rights Reserved
Back to Top